- Raymond James raised CSX Corporation (NASDAQ: NASDAQ:CSX) price target from $31 to $33. Raymond James analyst Patrick Tyler Brown maintained the stock with an Outperform rating. CSX shares rose 1.7% to close at $27.54 on Friday.
- Keybanc cut the price target on Match Group (NASDAQ:MTCH), Inc. (NASDAQ: MTCH) from $82 to $74. Keybanc analyst Justin Patterson maintained an Overweight rating on the stock. Match Group shares fell 0.5% to $42.77 in pre-market trading.
- BMO Capital lowered Green Plains Inc. (NASDAQ: GPRE) price target from $45 to $31. BMO Capital analyst Kenneth Zaslow downgraded the stock from Outperform to Market Perform. Green Plains shares rose 5.2% to close at $29.02 on Friday.
- Piper Sandler cut NovoCure Limited (NASDAQ: NVCR) price target from $90 to $70. Piper Sandler analyst Jason Bednar downgraded the stock from Overweight to Neutral. NovoCure fell 1.5% to $71.55 in pre-market trading.
- Barclays (LON:BARC) cut Analog Devices (NASDAQ:ADI), Inc. (NASDAQ: ADI) price target from $180 to $140. Barclays analyst Blayne Curtis downgraded the stock from Overweight to Equal-Weight. Analog Devices shares fell 1.6% to $144.29 in pre-market trading.
- HC Wainwright & Co cut Talaris Therapeutics, Inc. (NASDAQ: TALS) price target from $18 to $12. HC Wainwright & Co. analyst Raghuram Selvaraju maintained a Buy rating on the stock. Talaris Therapeutics shares fell 2.8% to $1.38 in pre-market trading.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.